60-minute Program
Effective dates for CE credit: 6/11/2026 – 6/11/2028
Description
This session will provide a background of DSMES reimbursement, including an overview of the DSMT benefit for CMS beneficiaries with diabetes. A description of DSMT billing codes and reimbursement requirements for providing the service will be covered. The presenter will provide an overview of the current state of telehealth and DSMT in addition to insights that can maximize your value and increase sustainability of your services.
Learning Outcome
Learners will report increased confidence in utilizing DSMT billing requirements, telehealth options, and practical strategies to improve reimbursement and long-term sustainability of DSMES programs.
Learning Objectives
At the end of this presentation, participants will be able to:
• Define the Medicare DSMT benefit
• Discuss telehealth options for DSMT
• Summarize DSMT billing requirements
• List common reasons for denied claims.
• State 2 strategies for sustaining DSMT services
Activity Type
This recording of a live presentation is a knowledge-based learning activity.
Learning Format
Enduring Material
Intended Audience
This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.
Faculty Disclosures
In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.
Joint Accreditation/ACCME requires ADCES to identify and mitigate all relevant financial relationships with ineligible companies to ensure educational content is balanced, evidence-based, and free from bias. Disclosure information is provided to help learners recognize any relevant financial relationships and make their own informed judgments about the content. If you perceive any bias during the activity, please report it through the evaluation form.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:
Planners
Marsha Schofield MS, RD, LD, FAND - No relevant financial relationships
Julia Socke, RDN, LDN, CDCES - No relevant financial relationships
Presenters
Marsha Schofield MS, RD, LD, FAND - No relevant financial relationships
Peer Reviewers
Ann Marie Barilla, MHSc, RDN, LDN, CDCES, BC-ADM - No relevant financial relationships
Jocelyn Protopappas, MSW, MPH, RDN - No relevant financial relationships
Charles D. Ponte, BS Pharm, PharmD, BC-ADM, CDCES - No relevant financial relationships
Cathriya Penny, DNP, ACHPN, FNP-BC, GNP-BC, CCP, BC-ADM - No relevant financial relationships
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
Financial Support
None
Pricing
This webinar is FREE and open to DEAP Coordinators ONLY.
ADCES CBs and LNGs: Please contact us at [email protected] to order a recorded webinar for a group viewing.
Not an ADCES member? Join today to get discounted member pricing on all events and products!
Access Period
You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).
Originally presented on: 6/11/2026
Expiration date: 6/11/2028